Abstract:Background: Tumor suppressor genes (TSGs) encode the guardian molecules to control cell growth. The genomic alteration of TSGs may cause tumorigenesis and promote cancer progression. So far, investigators have mainly studied the functional effects of somatic single nucleotide variants in TSGs. Copy number variation (CNV) is another important form of genetic variation, and is often involved in cancer biology and drug treatment, but studies of CNV in TSGs are less represented in literature. In addition, there is a lack of a combinatory analysis of gene expression and CNV in this important gene set. Such a study may provide more insights into the relationship between gene dosage and tumorigenesis. To meet this demand, we performed a systematic analysis of CNVs and gene expression in TSGs to provide a systematic view of CNV and gene expression change in TSGs in pan-cancer.Results: We identified 1170 TSGs with copy number gain or loss in 5846 tumor samples. Among them, 207 TSGs tended to have copy number loss (CNL), from which fifteen CNL hotspot regions were identified. The functional enrichment analysis revealed that the 207 TSGs were enriched in cancer-related pathways such as P53 signaling pathway and the P53 interactome. We further performed integrative analyses of CNV with gene expression using the data from the matched tumor samples. We found 81 TSGs with concordant CNL events and decreased gene expression in the tumor samples we examined. Remarkably, seven TSGs displayed concordant CNL and gene down-regulation in at least 50 tumor samples: MTAP (212 samples), PTEN (139), MCPH1 (85), FBXO25 (67), SMAD4 (64), TRIM35 (57), and RB1 (54). Specifically to MTAP, this concordance was found in 14 cancer types, an observation that is not much reported in literature yet. Further network-based analysis revealed that these TSGs with concordant CNL and gene down-regulation were highly connected.Conclusions: This study provides a draft landscape of CNV in pan-cancer. Our findings of systematic concordance between CNL and down-regulation of gene expression may help better understand the TSG biology in tumorigenesis and cancer progression.

Copy number profiling of tumor suppressor genes in head and neck cancer

High-Resolution Genomic And Expression Analyses Of Copy Number Alterations In Breast Tumors

Identification of copy number alternation profiles in metastatic oral squamous carcinoma patients by using microarray-based comparative genomic hybridization: A study on Turkish patients

Signatures of copy number alterations in human cancer

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: Four cases of homozygous deletions of the CDKN2A gene

The landscape of somatic copy-number alteration across human cancers

Prognostic Significance Of Copy-Number Alterations In Multiple Myeloma

Functional Genomic Analysis of Chromosomal Aberrations in a Compendium of 8000 Cancer Genomes

Mutation frequency and copy number alterations determine prognosis and metastatic tropism in 60,000 clinical cancer samples

Prognostic Relevance of Copy Number Losses in Ovarian Cancer

Genome-wide Analysis of Neuroblastomas Using High-Density Single Nucleotide Polymorphism Arrays.

Identification of Chromosomal Copy Number Variations and Novel Candidate Loci in Hereditary Nonpolyposis Colorectal Cancer with Mismatch Repair Proficiency

Concordance of Copy Number Loss and Down-Regulation of Tumor Suppressor Genes: a Pan-Cancer Study

Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors

Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer

GSTM1 Copy Number and Promoter Haplotype As Predictors for Risk of Recurrence And/or Second Primary Tumor in Patients with Head and Neck Cancer

Prevalence, causes and impact of TP53-loss phenocopying events in human tumors

Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.

Sensitive detection of copy number alterations in samples with low circulating tumor DNA fraction

Identification of Genes with A Correlation Between Copy Number and Expression in Gastric Cancer

Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer